from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3485c/-

LFCtreatmentdescriptionclass of inhibitor

0.515

Amikacinug/mL Amikacintranslation

1.388

Cap5-10ug/mL Capreomycintranslation

1.503

Rox10-50 ug/mL Roxithromycintranslation

0.050

SM2-5 ug/mL Streptomycintranslation

2.398

Tet5-10 ug/mL Tetracyclinetranslation

-1.152

Rif0.2-5ug/mL Rifampicintranscription

-0.141

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.511

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.384

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.162

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.225

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.848

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.361

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.630

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.006

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.151

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.389

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.439

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.424

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.949

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.316

KCN5-20 ug/mL Potassium cyaniderespiration

-0.250

NaN30.2-2 mM Sodium aziderespiration

0.303

Nigericin50 uM Nigericinrespiration

-0.459

TRC10-150 ug/mL Triclosanrespiration

-1.340

TRZ10-25 ug/mL Thioridazinerespiration

3.337

Valinomycin0.5-10 uM Valinomycinrespiration

0.528

ZnSO42 mM ZnSO4respiration

0.881

menadione6-10 ug/mL Menadionerespiration

0.488

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.724

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.113

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.394

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.186

NRP_1Non-replicating persistence stage 1dosRassociated

0.273

Amp0.2mg/mL AmpicillincellWall

0.190

Cephalexin20-100 ug/mL CephalexincellWall

-0.501

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.715

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.085

EMB10-20 ug/mL EthambutolcellWall

0.313

Eta12-40 ug/mL EthionamidecellWall

0.431

INH0.2-0.4 ug/mL IsoniazidcellWall

0.247

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.486

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.617

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.065

BZA0.12 mg/mL BenzamidearomaticAmides

-0.355

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.395

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.412

H2O24 mM hydrogen peroxideDNAdamaging

-0.059

Levo10 ug/mL LevofloxacinDNAdamaging

-0.801

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.284

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.058

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.014

UVUV-irradiationDNAdamaging

0.617

ARP41-4 ug/mL Antitubercular compound ARP4?

0.145

Antimycin12.5-50 ug/mL Antimycin A?

0.161

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.065

PA_110-50 ug/mL Antitubercular compound PA-1?

0.857

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.168

PA8240.2-2 ug/mL PA-824?

0.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.131

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.199

Verapamil50 uM Verapamil?

0.824

mercaptoethanol2 mM 2-Mercaptoethanol?

0.475

methoxatin10-20 ug/mL Methoxatin?